Results 281 to 290 of about 378,238 (343)

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

Lancet, The, 2010
Pier Luigi Zinzani
exaly   +2 more sources

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial

Lancet Oncology, The, 2016
Anna-Maria Fink, Christian Maurer, Clemens-Martin Wendtner   +2 more
exaly   +2 more sources

Cyclophosphamide

Reactions Weekly, 2019
semanticscholar   +3 more sources

Protective effect of myricetin, apigenin, and hesperidin pretreatments on cyclophosphamide-induced immunosuppression

Immunopharmacology and immunotoxicology, 2021
Aim: Major side effects of cyclophosphamide administration are immunosuppression and myelosuppression. The immunomodulatory effects of plant bioactive compounds on chemotherapy drug-induced immunosuppression may have significant effects in cancer ...
M. Berköz, S. Yalın, Ferbal Özkan-Yılmaz, Arzu Özlüer-Hunt, M. Krośniak, R. Francik, O. Yunusoğlu, Abdullah Adıyaman, Hava Gezici, Ayhan Yiğit, Sedat Ünal, Davut Volkan, M. Yıldırım   +12 more
semanticscholar   +1 more source

Molecular mechanism involved in cyclophosphamide‐induced cardiotoxicity: Old drug with a new vision

Life Science, 2019
Cyclophosphamide (CP) is an important anticancer drug which belongs to the class of alkylating agent. Cyclophosphamide is mostly used in bone marrow transplantation, rheumatoid arthritis, lupus erythematosus, multiple sclerosis, neuroblastoma and other ...
Ashif Iqubal, M. Iqubal, Sumit Sharma, M. Ansari, A. Najmi, S. M. Ali, J. Ali, S. Haque   +7 more
semanticscholar   +1 more source

Cyclophosphamide cardiotoxicity

European Journal of Pediatrics, 1980
A 12-year-old boy with aplastic anemia developed severe but reversible cardiac failure after treatment with 200 mg/kg cyclophosphamide (4 x 50 mg/kg on four consecutive days) given as preparation for bone marrow grafting. This and previously reported cases demonstrate the possibility of cardiotoxicity after high doses of the drug.
G, von Bernuth, D, Adam, R, Hofstetter, D, Lang, W, Mohr, E, Kohne, D, Niethammer   +6 more
openaire   +2 more sources

Does cyclophosphamide still play a role in glomerular diseases?

Autoimmunity Reviews, 2018
Cyclophosphamide is a prodrug that is converted to inactive carboxy-cyclophosphamide, acrolein and phosphoramide mustard, an agent that adds alkyl groups to oxygen and nitrogen atoms of guanine, one of the four nitrogen bases that form the DNA ...
C. Ponticelli, R. Escoli, G. Moroni
semanticscholar   +1 more source